Genetics Company and Zymo Research Europe Shine at MEDLAB Dubai 2019

Image
09 February 2019

Genetics Company and Zymo Research Europe Shine at MEDLAB Dubai 2019

Dubai, UAE – Genetics Company for Biotechnology proudly announces its successful participation alongside Zymo Research Europe at the prestigious MEDLAB conference held in Dubai in 2019. This collaborative endeavor showcased cutting-edge innovations in biotechnology and underscored our commitment to advancing healthcare through groundbreaking research and development.

MEDLAB Dubai 2019 served as a platform for industry leaders, healthcare professionals, and researchers to explore the latest advancements in laboratory medicine and diagnostics. As exhibitors, Genetics Company and Zymo Research Europe captivated attendees with their state-of-the-art solutions and unrivaled expertise in molecular biology and biotechnology.

The event provided an unparalleled opportunity for Genetics Company and Zymo Research Europe to showcase their extensive range of products and services, including molecular biology kits, nucleic acid extraction solutions, and advanced research tools. Attendees had the chance to engage with experts from both organizations, gaining insights into the latest trends and technologies shaping the field of laboratory medicine.

"Our participation in MEDLAB Dubai 2019 reaffirms our commitment to driving innovation and excellence in biotechnology," said Omar Lafi the CEO of Genetics Company. "Collaborating with Zymo Research Europe has enabled us to showcase our combined strengths and demonstrate the transformative impact of our products on healthcare and research."

As leaders in their respective domains, Genetics Company and Zymo Research Europe leveraged their presence at MEDLAB Dubai to forge new partnerships, foster collaborations, and exchange knowledge with industry peers and stakeholders. The event served as a testament to their shared vision of advancing scientific discovery and improving patient outcomes worldwide.

Moving forward, Genetics Company and Zymo Research Europe remain dedicated to pushing the boundaries of possibility in biotechnology and laboratory medicine. By harnessing the power of innovation and collaboration, they continue to drive positive change and shape the future of healthcare.

Stay tuned for updates on our upcoming events and initiatives as we continue to make strides in the field of biotechnology.

Share It: